SMT201600419B - Composizione farmaceutica contenente fosfolipidi - Google Patents

Composizione farmaceutica contenente fosfolipidi

Info

Publication number
SMT201600419B
SMT201600419B SM201600419T SM201600419T SMT201600419B SM T201600419 B SMT201600419 B SM T201600419B SM 201600419 T SM201600419 T SM 201600419T SM 201600419 T SM201600419 T SM 201600419T SM T201600419 B SMT201600419 B SM T201600419B
Authority
SM
San Marino
Prior art keywords
phospholipides
pharmaceutical composition
composition containing
pharmaceutical
containing phospholipides
Prior art date
Application number
SM201600419T
Other languages
English (en)
Inventor
Bernd G Seigfried
Original Assignee
Mika Pharma Ges Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mika Pharma Ges Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh filed Critical Mika Pharma Ges Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh
Publication of SMT201600419B publication Critical patent/SMT201600419B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
SM201600419T 2012-05-15 2016-11-18 Composizione farmaceutica contenente fosfolipidi SMT201600419B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012009575 2012-05-15
DE102013004199A DE102013004199A1 (de) 2012-05-15 2013-03-12 Pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
SMT201600419B true SMT201600419B (it) 2017-01-10

Family

ID=47901750

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600419T SMT201600419B (it) 2012-05-15 2016-11-18 Composizione farmaceutica contenente fosfolipidi

Country Status (18)

Country Link
EP (1) EP2638894B1 (it)
JP (1) JP2013237669A (it)
BR (1) BR102013011801B1 (it)
CA (1) CA2815477C (it)
CY (1) CY1118727T1 (it)
DE (1) DE102013004199A1 (it)
DK (1) DK2638894T3 (it)
ES (1) ES2606031T3 (it)
HR (1) HRP20161318T1 (it)
HU (1) HUE029793T2 (it)
LT (1) LT2638894T (it)
MX (1) MX342069B (it)
PL (1) PL2638894T3 (it)
PT (1) PT2638894T (it)
RS (1) RS55291B1 (it)
RU (1) RU2659943C2 (it)
SI (1) SI2638894T1 (it)
SM (1) SMT201600419B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209542D1 (de) * 1991-07-05 1998-12-03 Rhone Poulenc Rorer Gmbh Phospholipidische Zusammensetzung
US6113921A (en) * 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
DE4313402A1 (de) * 1993-04-23 1994-10-27 Hexal Pharma Gmbh Transdermale Wirkstoffzubereitung
PT746294E (pt) * 1993-10-07 2005-03-31 Odontex Inc Promotores de absorcao para formulacoes farmaceuticas topicas
DE19536246A1 (de) 1994-09-30 1996-04-04 Juergen Dr Regenold Pharmazeutische Zusammensetzung
US20080193393A1 (en) * 2004-09-24 2008-08-14 Lipo Chemicals Inc. Delivery System for Topically Applied Compounds
US20110269704A1 (en) * 2009-07-24 2011-11-03 Seigfried Bernd G Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically

Also Published As

Publication number Publication date
RS55291B1 (sr) 2017-03-31
CY1118727T1 (el) 2017-07-12
HRP20161318T1 (hr) 2016-12-16
LT2638894T (lt) 2017-02-10
JP2013237669A (ja) 2013-11-28
CA2815477A1 (en) 2013-11-15
EP2638894A1 (de) 2013-09-18
MX2013005306A (es) 2013-11-26
PL2638894T3 (pl) 2017-02-28
EP2638894B1 (de) 2016-09-14
DK2638894T3 (en) 2016-10-17
BR102013011801B1 (pt) 2022-08-09
PT2638894T (pt) 2016-12-13
RU2659943C2 (ru) 2018-07-04
RU2013121269A (ru) 2014-11-20
CA2815477C (en) 2017-05-02
MX342069B (es) 2016-09-13
ES2606031T3 (es) 2017-03-17
DE102013004199A1 (de) 2013-11-21
SI2638894T1 (sl) 2017-01-31
BR102013011801A2 (pt) 2015-11-10
HUE029793T2 (en) 2017-04-28

Similar Documents

Publication Publication Date Title
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
DK2890256T3 (da) Nikotinsammensætning
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
BR112015002738A2 (pt) composto , e , composição farmacêutica
DK2694038T3 (da) Farmaceutisk sammensætning
BR112015002651A2 (pt) composições cosméticas
FR2997014B1 (fr) Composition sterile dermo-injectable
BR112014032798A2 (pt) composição
BR112015004936A2 (pt) composição farmacêutica revestida contendo regorafenib
ZA201501930B (en) Pharmaceutical composition
EP2931285A4 (en) PHARMACEUTICAL COMPOSITIONS
DK2897594T3 (da) Farmaceutisk sammensætning
ZA201501928B (en) Pharmaceutical antiretroviral composition
DK2815752T3 (da) Oral farmaceutisk sammensætning
EP2832730A4 (en) MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
IL266415A (en) Innovative pharmaceutical composition
BR112015010797A2 (pt) compostos aniônicos substituídos, e, composição farmacêutica
HK1210710A1 (en) Pharmaceutical composition comprising rebamipide
BR112015003116A2 (pt) preparação farmacêutica sólida contendo levotiroxina
BR112014032712A2 (pt) composição
BR112015002646A2 (pt) composto e composição farmacêutica
SMT201600419B (it) Composizione farmaceutica contenente fosfolipidi
DK2811828T3 (da) Adjuvanssammensætninger
ZA201502987B (en) Pharmaceutical composition
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION